Anti-Apoptotic and Anti-Inflammatory Role of Trans ε-Viniferin in a Neuron-Glia Co-Culture Cellular Model of Parkinson's Disease.
Parkinson’s disease
apotosis
dopamine
neuroinflammation
neuroprotection
oxidative stress
resveratrol
trans-ε-viniferin
Journal
Foods (Basel, Switzerland)
ISSN: 2304-8158
Titre abrégé: Foods
Pays: Switzerland
ID NLM: 101670569
Informations de publication
Date de publication:
11 Mar 2021
11 Mar 2021
Historique:
received:
12
02
2021
revised:
06
03
2021
accepted:
07
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
4
4
2021
Statut:
epublish
Résumé
The polyphenol trans-ε-viniferin (viniferin) is a dimer of resveratrol, reported to hold antioxidant and anti-inflammatory properties. The aims of our study were to evaluate the neuroprotective potential of viniferin in the nerve growth factor (NGF)-differentiated PC12 cells, a dopaminergic cellular model of Parkinson's disease (PD) and assess its anti-inflammatory properties in a N9 microglia-neuronal PC12 cell co-culture system. The neuronal cells were pre-treated with viniferin, resveratrol or their mixture before the administration of 6-hydroxydopamine (6-OHDA), recognized to induce parkinsonism in rats. Furthermore, N9 microglia cells, in a co-culture system with neuronal PC12, were pre-treated with viniferin, resveratrol or their mixture to investigate whether these polyphenols could reduce lipopolysaccharide (LPS)-induced inflammation. Our results show that viniferin as well as a mixture of viniferin and resveratrol protects neuronal dopaminergic cells from 6-OHDA-induced cytotoxicity and apoptosis. Furthermore, when viniferin, resveratrol or their mixture was used to pre-treat microglia cells in our co-culture system, they reduced neuronal cytotoxicity induced by glial activation. Altogether, our data highlight a novel role for viniferin as a neuroprotective and anti-inflammatory molecule in a dopaminergic cellular model, paving the way for nutraceutical therapeutic avenues in the complementary treatments of PD.
Identifiants
pubmed: 33799534
pii: foods10030586
doi: 10.3390/foods10030586
pmc: PMC7998636
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Natural Sciences and Engineering Research Council of Canada
ID : 04321
Références
PLoS One. 2019 Feb 20;14(2):e0212663
pubmed: 30785960
Parkinsons Dis. 2011;2011:327089
pubmed: 21603177
Rejuvenation Res. 2012 Jun;15(3):322-33
pubmed: 22524206
Neurochem Res. 2008 Dec;33(12):2416-26
pubmed: 18415676
Neurotox Res. 2014 Jan;25(1):110-23
pubmed: 24218232
Neural Regen Res. 2020 Nov;15(11):2143-2153
pubmed: 32394973
Front Neuroanat. 2015 Jul 08;9:91
pubmed: 26217195
Biomol Ther (Seoul). 2012 May;20(3):306-12
pubmed: 24130928
Biofactors. 2018 Jan;44(1):36-49
pubmed: 29193412
J Sep Sci. 2016 Jun;39(12):2374-9
pubmed: 27130423
J Neural Transm Suppl. 2006;(70):9-15
pubmed: 17017502
J Vis Exp. 2016 Jul 17;(113):
pubmed: 27500972
J Neurosci Res. 2008 Feb 1;86(2):403-10
pubmed: 17929310
Neurotox Res. 2007 Apr;11(3-4):151-67
pubmed: 17449457
Ann N Y Acad Sci. 2003 Jun;991:111-9
pubmed: 12846980
J Biol Chem. 2012 Jul 13;287(29):24460-72
pubmed: 22648412
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1243-50
pubmed: 18471948
Naunyn Schmiedebergs Arch Pharmacol. 2018 Apr;391(4):445-453
pubmed: 29411055
Exp Gerontol. 2019 Sep;124:110653
pubmed: 31295526
Cell Mol Life Sci. 2013 Nov;70(22):4259-73
pubmed: 23665870
Oxid Med Cell Longev. 2012;2012:921941
pubmed: 22919443
J Toxicol. 2011;2011:392859
pubmed: 21776258
Cancer Sci. 2009 Sep;100(9):1655-62
pubmed: 19496785
Neuroscience. 2017 Oct 11;361:144-156
pubmed: 28823819
J Immunol Methods. 1988 Nov 25;115(1):61-9
pubmed: 3192948
Oxid Med Cell Longev. 2014;2014:425496
pubmed: 25574337
J Neurochem. 1998 Apr;70(4):1584-92
pubmed: 9580157
J Histochem Cytochem. 2001 Mar;49(3):369-78
pubmed: 11181740
J Neural Transm (Vienna). 2014 Oct;121(10):1245-57
pubmed: 24627045
Biomed Pharmacother. 2020 Jul;127:110234
pubmed: 32559855
Mol Cell Neurosci. 2018 Apr;88:1-6
pubmed: 29223600
J Nat Prod. 2014 Jul 25;77(7):1658-62
pubmed: 25014026
Chem Cent J. 2018 Feb 13;12(1):14
pubmed: 29442202
Biochem Soc Trans. 2015 Aug;43(4):621-6
pubmed: 26551702
Front Aging Neurosci. 2019 Nov 08;11:302
pubmed: 31787891
Neurobiol Dis. 2010 Mar;37(3):510-8
pubmed: 19913097
J Neurosci Res. 2002 Oct 1;70(1):90-6
pubmed: 12237867
Cell Mol Neurobiol. 2009 Dec;29(8):1169-80
pubmed: 19466539
Sci Rep. 2019 Apr 8;9(1):5790
pubmed: 30962497
Anat Rec (Hoboken). 2018 Jun;301(6):1115-1125
pubmed: 29350822
Neurobiol Dis. 2000 Aug;7(4):429-47
pubmed: 10964613
J Immunol Res. 2018 Apr 16;2018:4784268
pubmed: 29850629
Evid Based Complement Alternat Med. 2015;2015:730121
pubmed: 26681969
Parkinsonism Relat Disord. 2004 May;10 Suppl 1:S3-7
pubmed: 15109580
Neurology. 1988 Aug;38(8):1285-91
pubmed: 3399080
Hum Mol Genet. 2014 Mar 15;23(6):1435-52
pubmed: 24158851
Arch Pharm Res. 2010 Oct;33(10):1655-64
pubmed: 21052941
Antioxidants (Basel). 2020 Aug 13;9(8):
pubmed: 32823544
J Neural Transm (Vienna). 2005 Mar;112(3):331-47
pubmed: 15503194
Ann Neurol. 2003;53 Suppl 3:S61-70; discussion S70-2
pubmed: 12666099
Oxid Med Cell Longev. 2015;2015:610813
pubmed: 25834699
Amino Acids. 2013 Aug;45(2):393-401
pubmed: 23712764
Neurotoxicology. 1984 Spring;5(1):77-82
pubmed: 6326007
Front Aging Neurosci. 2020 Apr 17;12:103
pubmed: 32362821
Neurobiol Dis. 2014 Jul;67:191-202
pubmed: 24632419